|
 |
|
Innovative Pseudomonas Diagnostic Technologies and Emerging Markets
The report contains 198 pages, 7 tables and presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pseudomonas definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
 |
|
$3850.00 |
| |
|
|
|
Innovative Rabies Diagnostic Technologies and Emerging Markets
The report contains 197 pages, 8 tables and presents a detailed analysis of the Rabies diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rabies definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Rhinovirus Diagnostic Technologies and Emerging Markets
The report contains 194 pages, 7 tables and presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Rotavirus Diagnostic Technologies and Emerging Markets
The report contains 205 pages, 15 tables and presents a detailed analysis of the Rotavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rotavirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative RSV Diagnostic Technologies and Emerging Markets
The report contains 227 pages, 15 tables and presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Rubella Diagnostic Technologies and Emerging Markets
The report contains 235 pages, 15 tables and presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Salmonella Diagnostic Technologies and Emerging Markets
The report contains 221 pages, 9 tables and presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Septicemia Diagnostic Technologies and Emerging Markets
The report contains 202 pages, 15 tables and presents a detailed analysis of the Septicemia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Septicemia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Shigella Diagnostic Technologies and Emerging Markets
The report contains 220 pages, 12 tables and presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Shigella definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Streptococci Diagnostic Technologies and Emerging Markets
The report contains 205 pages, 14 tables and presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Streptococci definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Syphilis Diagnostic Technologies and Emerging Markets
The report contains 231 pages, 15 tables and presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Toxoplasmosis Diagnostic Technologies and Emerging Markets
The report contains 226 pages, 15 tables and presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Tuberculosis Diagnostic Technologies and Emerging Markets
The report contains 208 pages, 15 tables and presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Vibrio Diagnostic Technologies and Emerging Markets
The report contains 200 pages, 7 tables and presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Vibrio definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Yersinia Diagnostic Technologies and Emerging Markets
The report contains 197 pages, 8 tables and presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
US Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the US infectious disease testing market, including:- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms....
|
|
|
$3850.00 |
| |
|
|
|
Emerging Opportunities in the US Virology and Bacteriology Testing Market
�Emerging Opportunities in the US Virology and Bacteriology Testing Market� is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
|
|
|
$3850.00 |
| |
|
|
|
Hepatitis Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--France, Germany, Italy, Japan, Spain, UK, USA--Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
This report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT assays performed in the following markets:
|
|
|
$3850.00 |
| |
|
|
|
|